XML 37 R5.htm IDEA: XBRL DOCUMENT v2.4.0.8
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
6 Months Ended 291 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Operating activities:      
Net loss $ (10,433) $ (16,790) $ (280,787)
Adjustments to reconcile net loss to net cash used for operating activities:      
Depreciation and amortization 275 341 8,422
Loss on property held for resale     110
Amortization of discounts and premiums on investments     (1,704)
Stock compensation expense 383 2,039 17,878
Decrease due to change in fair value of warrants (1,964) (1,048) (18,501)
Inventory write downs and reserves     2,240
Stock issued pursuant to license agreement     3,300
Provision for losses on accounts receivable     204
Changes in operating assets and liabilities:      
Inventories     (2,335)
Other current assets 116 181 (465)
Accounts payable and accrued expenses 87 821 3,102
Accrued employee benefits 75 (97) 458
Net cash used for operating activities (11,461) (14,553) (268,078)
Investing activities:      
Organizational costs     (73)
Purchase of short-term investments     (217,041)
Maturities of short-term investments     218,745
Property and equipment purchases (40) (86) (7,530)
Proceeds from sale of property held for resale     400
Net cash used for investing activities (40) (86) (5,499)
Financing activities:      
Net proceeds from issuance of preferred stock   37,620 89,267
Net proceeds from issuance of common stock and warrants 2,378 176 187,432
Payments received for stock purchase rights and other, net     3,500
Proceeds from long-term debt     751
Principal payments under long-term debt obligations (21) (21) (2,861)
Other, net     (18)
Net cash provided by financing activities 2,357 37,775 278,071
Net increase (decrease) in cash and cash equivalents (9,144) 23,136 4,494
Cash and cash equivalents at beginning of period 13,638 5,530  
Cash and cash equivalents at end of period 4,494 28,666 4,494
Supplemental cash flow information (non-cash):      
Accretion of convertible preferred stock 1,263 1,520 6,224
Warrants exchanged for common stock   $ 8,356 $ 10,382